0000897069-25-000101.txt : 20250113 0000897069-25-000101.hdr.sgml : 20250113 20250113153333 ACCESSION NUMBER: 0000897069-25-000101 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20250113 DATE AS OF CHANGE: 20250113 EFFECTIVENESS DATE: 20250113 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cambrian BioPharma Inc CENTRAL INDEX KEY: 0001797409 ORGANIZATION NAME: IRS NUMBER: 842985609 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-500632 FILM NUMBER: 25526223 BUSINESS ADDRESS: STREET 1: 228 PARK AVENUE S. STREET 2: #66643 CITY: NEW YORK STATE: NY ZIP: 10003 BUSINESS PHONE: (516) 962-3186 MAIL ADDRESS: STREET 1: 228 PARK AVENUE S. STREET 2: #66643 CITY: NEW YORK STATE: NY ZIP: 10003 FORMER COMPANY: FORMER CONFORMED NAME: Cambrian BioPharma Inc. DATE OF NAME CHANGE: 20191219 D/A 1 primary_doc.xml X0708 D/A LIVE 0001797409 Cambrian BioPharma Inc 228 PARK AVENUE S. #66643 NEW YORK NY NEW YORK 10003 (516) 962-3186 DELAWARE Cambrian BioPharma Inc. Corporation true James G. Peyer 228 Park Avenue S. #66643 New York NY NEW YORK 10003 Executive Officer Director Christian Angermayer 228 Park Avenue S. #66643 New York NY NEW YORK 10003 Director Maryanna Saenko 228 Park Avenue S. #66643 New York NY NEW YORK 10003 Director Brenton Saunders 228 Park Avenue S. #66643 New York NY NEW YORK 10003 Director Paul Farr 228 Park Avenue S. #66643 New York NY NEW YORK 10003 Director Pharmaceuticals Decline to Disclose 06b true 0000897069-23-001843 2023-06-02 true true true Simple Agreement for Future Equity false 0 37602297 23022065 14580232 false 30 0 0 0 false Cambrian BioPharma Inc /s/ James G. Peyer James G. Peyer Chief Executive Officer 2025-01-10